Costs of type 2 diabetes mellitus from payers’ perspective: a study from real-world evidence of district hospital in Vietnam

Download full text PDF
DOI: https://doi.org/10.29296/25419218-2020-04-07
Issue: 
4
Year: 
2020

Nguyen T.T.Т.(1), Nguyen T.T(1), Pham T.T.L.(2), Le Q.N.(1), Nguyen M.Q.(2) 1-Faculty of Pharmacy, University of Medicine and Pharmacy, Ho Chi Minh City, Viet Nam; 2-Thu Duc district hospital, Ho Chi Minh City, Viet Nam

Objective. Estimate yearly treatment cost of type 2 diabetes mellitus (T2DM) from payers’ perspective and its influencing factors. Method. A cross-sectional descriptive study has been conducted based on real-world evidence from Thu Duc district hospital from January 2017 to April 2018. Cost of T2DM was estimated based on payers’ perspective and included direct medical, direct non-medical and indirect costs. Result: Analyzing the sample of 206 patients with men: women rate of 1: 2.81 and mean age of 61.76±9.74, it has been shown that the average costs of T2DM per patient was accounted for US $ 1,038.3 (95% CI 951.4–1,125.2) with high proportion for direct costs (93.7%) and drugs cost (68.4% of direct medical costs and 60.6% of total costs). Costs per patient with complication was accounted for US $ 1,677.2 (95% CI 1,541.3–1,813.1), which is higher than those without complications (US $ 306.3 (95% CI 295.7–316.9)). Patients with comorbidities incurred higher average cost than those without them (p
Keywords: 
Costs
Type 2 diabetes mellitus
Payer’s perspective
Vietnam
References: 
  1. Association American Diabetes (2013), «Economic costs of diabetes in the US in 2012», Diabetes care. 36 (4): 1033–46.
  2. Association American Diabetes (2013), «Economic costs of diabetes in the US in 2012. Diabetes Care. 2013; 36: 1033–46», Diabetes care. 36 (6): 1797.
  3. Association American Diabetes (2016), «Standards of medical care in diabetes—2016 abridged for primary care providers», Clinical diabetes: a publication of the American Diabetes Association. 2016; 34 (1): 3.
  4. Bahia Luciana R. et al., «The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system», Value in Health. 2011; 14 (5): 137–40.
  5. Bloomberg, «https://www.bloomberg.com/quote/USDVND:CUR». Accessed: June 17, 2018.
  6. Bloomberg, «www.bloomberg.com/quote/USDVND:CUR». Acessess: June 9, 2018.
  7. Cao Ping et al., «Factors influencing the hospitalization costs of patients with type 2 diabetes», Asia Pacific Journal of Public Health. 2015; 27 (2_suppl): 55–60.
  8. Chatterjee Susmita et al., «Cost of diabetes and its complications in Thailand: a complete picture of economic burden», Health & social care in the community. 2011; 19 (3): 289–98.
  9. Esteghamati A. et al. «The economic costs of diabetes: a population-based study in Tehran, Iran», Diabetologia. 2009; 52 (8): 1520–7.
  10. Gardner David G. et al. Greenspan's basic & clinical endocrinology, McGraw-Hill Medical. 2007.
  11. Internasional Diabetes Federation. «IDF diabetes atlas», Brussels: International Diabetes Federation. 2013.
  12. Köster Ingrid et al. «Direct costs of diabetes mellitus in Germany–CoDiM 2000–2007», Experimental and Clinical Endocrinology & Diabetes. 2011; 119 (06): 377–85.
  13. Le Nguyen Tu Dang et al. «Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study», Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2017; 10: 363.
  14. Lee Crystal Man Ying et al. «The cost of diabetes in adults in Australia», Diabetes Research and Clinical Practice. 2013; 99 (3): 385–90.
  15. Ng Charmaine Shuyu et al. «Direct medical cost of type 2 diabetes in Singapore», PloS one. 2015; 10 (3): e0122795.
  16. Nguyen Chung T. et al. «Prevalence of and risk factors for type 2 diabetes mellitus in Vietnam: a systematic review», Asia Pacific Journal of Public Health. 2015; 27 (6): 588–600.
  17. Organization World Health, Global report on diabetes, World Health Organization. 2016.
  18. Shi Yuankai et al. «The global implications of diabetes and cancer», The Lancet. 2014; 383 (9933): 1947–8.
  19. Shourov D.M. A Survey on Prescription Pattern of Diabetes Mellitus, East West University. 2017.
  20. Solli Oddvar et al. «Diabetes: cost of illness in Norway», BMC endocrine disorders. 2010; 10 (1): 15.
  21. Tao Ziqi et al. «Epidemiological perspectives of diabetes», Cell biochemistry and biophysics. 2015; 73 (1): 181–5.
  22. Tharkar Shabana et al. «The socioeconomics of diabetes from a developing country: a population based cost of illness study», Diabetes Research and Clinical Practice. 2010; 89 (3): 334–40.
  23. The World Heaith Organization Representative Office in Viet Nam (2016), «The growing burden of diabetes in Viet Nam», WPRO, . Accessed: March 27, 2018.
  24. Wang Weibing et al. «Type 2 diabetes mellitus in China: a preventable economic burden», The American journal of managed care. 2009; 15 (9): 593–601.